Vaccine and Infectious Disease Organization


VIDO is a University of Saskatchewan research centre and a global leader in infectious disease research and vaccine development for humans and animals. With over 50 years of experience, VIDO develops solutions to emerging infectious disease threats, including playing a key role in Canada's COVID-19 response. The organization is expanding its capabilities as Canada's Centre for Pandemic Research, with new facilities and containment levels, to support vaccine and therapeutic development for humans and animals worldwide.

Industries

medical
pharmaceutical
product-research

Nr. of Employees

medium (51-250)

Vaccine and Infectious Disease Organization

University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada


Products

Vaccine Manufacturing

Production of vaccines for both human and animal health, utilizing containment level 3 capable biomanufacturing facilities.

Contract Research

Offering research services to government, academia, and industry partners, including access to specialized containment level 3 facilities.

Accessing CL3

Providing access to containment level 3 laboratories and animal isolation rooms for external researchers to conduct infectious disease research.

Canada's Centre for Pandemic Research

A dedicated center focused on pandemic preparedness and response, including vaccine development and containment level 4 capacity.

Training Programs

Providing training opportunities for students and postgraduates in various scientific disciplines, including international training programs and work experience placements.

Community Consultation

Engaging with the community through the Community Liaison Committee to ensure transparency and trust regarding safety and security at VIDO.


Services

Outsourced research and evaluation for vaccine and anti-infective development, including pathogenesis studies, animal model development, safety and efficacy testing under CL2 and CL3 containment.

Process development, technical transfer, and GMP manufacturing services for human clinical trial material (Phase 1–2) and commercial veterinary vaccines, using modular GMP-capable facilities and single-use manufacturing systems.

Expertise Areas

  • Vaccine research and development
  • Biomanufacturing and CDMO services
  • Animal model development and pathogenesis
  • High-containment biosafety operations
  • Show More (4)

Key Technologies

  • Single-use stirred-tank bioreactors (up to 1000 L)
  • Single-use fixed-bed bioreactor systems
  • Tangential flow filtration / hollow-fiber TFF
  • Depth filtration
  • Show More (6)

News & Updates

Lyme disease is becoming a growing threat — even in places like Saskatchewan. Dr. Jenny Wachter is uncovering how the Lyme-causing bacterium survives and spreads, laying the groundwork for better detection, treatment, and prevention.

A cross-campus collaboration between VIDO and WCVM created a new surgical suite that advances critical calf research while giving veterinary students rare surgical training opportunities.

A groundbreaking gut loop model developed at VIDO is advancing intestinal immunity research in calves, helping reduce animal use while offering new hope in the fight against Johne’s disease.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.